Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel
Use
This test is intended for individuals with relevant features who have a clinical or suspected diagnosis of a metabolic myopathy, individuals with recurrent episodes of rhabdomyolysis, or individuals with symptoms triggered by exercise, infection, fasting, or medications.
Special Instructions
This test requires specimens to be collected and shipped to PreventionGenetics. Ensure to sign in for standard institutional pricing and consider ordering additional testing options after receiving your report. For more details, visit PreventionGenetics.com.
Limitations
This panel covers 158 genes associated with metabolic myopathies, rhabdomyolysis, and exercise intolerance. The test is not FDA cleared or approved and has been validated under CAP and CLIA regulations.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided